Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Katalog Bibliotek Uniwersytetu Śląskiego i Uniwersytetu Ekonomicznego w Katowicach Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaKatalog Bibliotek Uniwersytetu Śląskiego i Uniwersytetu Ekonomicznego w Katowicach

Wyszukujesz frazę "Ma%C5%82e i %C5%9Brednie przedsi%C4%99biorstwa - rachunkowo%C5%9B%C4%87." wg kryterium: Wszystkie pola

  Lista filtrów

Ogranicz do:

Wyrównaj
Wyświetlanie 1-20 z 1892967
Tytuł:
Pegylated interferon alfa-2b and fixed versus weight-based ribavirin dosing for treatment naive patients with chronic hepatitis C: I Jacobson, Weill Medical College of Cornell University, New York, NY; R Brown, Columbia University College of Physicians and Surgeons, New York, NY; D Bernstein, North Shore Med Ctr, Manhasset, NY; C Bruno, Emory University, Atlanta, GA; J Spivey, Mayo Clinic, Jacksonville, FL; E Lawitz, Brooke Army Med Ctr, Ft Sam Houston, TX; N Afdhal, Beth Israel Med Ctr, Boston, MA; S Flamm, Northwestern Univ, Chicago, NY; B Freilich, Baptist Med Ctr, Kansas City, MO; O Pizov, M Russo, Weill Medical College of Cornell Univ, New York, NY; C Brass, Schering Plough Corp, Kenilworth, NJ; and a large US Multicenter Study Group
Źródło:
In Hepatology 2001 34(4) Part 2:A584-A584
Czasopismo naukowe
Szczegóły
Tytuł:
Commentary on “Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome.” Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, Rosty C, Arnold J, Levine AJ, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Hopper JL, Jenkins MA, Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Victoria, Australia: J Natl Cancer Inst 2012;104(18):1363-72 [Epub 2012 Aug 28]
Autorzy:
Kamat, Ashish M.
Pokaż więcej
Źródło:
In Urologic Oncology: Seminars and Original Investigations July 2013 31(5):716-716
Czasopismo naukowe
Szczegóły
Tytuł:
Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophreniaPlease cite this article as follows: Chavarría‐Siles I, Contreras‐Rojas J, Hare E, Walss‐Bass C, Quezada P, Dassori A, Contreras S, Medina R, Ramírez M, Salazar R, Raventos H, Escamilla MA. 2007. Cannabinoid Receptor 1 Gene (CNR1) and Susceptibility to a Quantitative Phenotype for Hebephrenic Schizophrenia. Am J Med Genet Part B 147B: 279–284.
Autorzy:
Chavarría‐Siles, Iván
Contreras‐Rojas, Javier
Hare, Elizabeth
Walss‐Bass, Consuelo
Quezada, Paulina
Dassori, Albana
Contreras, Salvador
Medina, Rolando
Ramírez, Mercedes
Salazar, Rodolfo
Raventos, Henriette
Escamilla, Michael A.
Pokaż więcej
Źródło:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics: The Official Publication of the International Society of Psychiatric Genetics; April 2008, Vol. 147 Issue: 3 p279-284, 6p
Periodyk
Szczegóły
Tytuł:
Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Jen JC, Chan WM, Bosley TM, Wan J, Carr JR, Rub U, Shattuck D, Salamon G, Kudo LC, Ou J, Lin DD, Salih MA, Kansu T, Al Dhalaan H, Al Zayed Z, MacDonald DB, Stigsby B, Plaitakis A, Dretakis EK, Gottlob I, Pieh C, Traboulsi EI, Wang Q, Wang L, Andrews C, Yamada K, Demer JL, Karim S, Alger JR, Geschwind DH, Deller T, Sicotte NL, Nelson SF, Baloh RW, Engle EC. Science 2004;304:1509–1513
Autorzy:
Grossniklaus, Hans E.
Pokaż więcej
Źródło:
In American Journal of Ophthalmology December 2004 138(6):1097-1097
Czasopismo naukowe
Szczegóły
Tytuł:
Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.
Autorzy:
Li H
Xu L
Li C
Zhao L
Ma Y
Zheng H
Li Z
Zhang Y
Wang R
Liu Y; Department of Medical Oncology, the First Hospital of China Medical University, NO,155, North Nanjing Street, Heping District, Shenyang 110001, China. .
Qu X
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2014 Jun 02; Vol. 13, pp. 136. Date of Electronic Publication: 2014 Jun 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Adaptor Proteins, Signal Transducing/*genetics
Adenocarcinoma/*genetics
Homeodomain Proteins/*genetics
Insulin-Like Growth Factor I/*metabolism
MicroRNAs/*genetics
Proto-Oncogene Proteins c-cbl/*genetics
Repressor Proteins/*genetics
Stomach Neoplasms/*genetics
Adaptor Proteins, Signal Transducing/antagonists & inhibitors ; Adaptor Proteins, Signal Transducing/metabolism ; Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Aged ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/drug effects ; Female ; Homeodomain Proteins/metabolism ; Humans ; Insulin-Like Growth Factor I/pharmacology ; Lymphatic Metastasis ; Male ; MicroRNAs/metabolism ; Middle Aged ; Mitogen-Activated Protein Kinase 3/antagonists & inhibitors ; Mitogen-Activated Protein Kinase 3/genetics ; Mitogen-Activated Protein Kinase 3/metabolism ; Neoplasm Staging ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins c-akt/antagonists & inhibitors ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Proto-Oncogene Proteins c-cbl/antagonists & inhibitors ; Proto-Oncogene Proteins c-cbl/metabolism ; RNA, Small Interfering/genetics ; RNA, Small Interfering/metabolism ; Repressor Proteins/metabolism ; Signal Transduction ; Stomach Neoplasms/metabolism ; Stomach Neoplasms/pathology ; Zinc Finger E-box Binding Homeobox 2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of anti-AIDS drugs in conventional mice implanted with a permeable membrane (hollow fiber) device containing human T cells infected with HIV: L. B. Allen 1, D. C. Quenelle 1, B. A. Taylor 1, B. J. Bowdon 1, K. Keith 1, A.D. Brazier 1, W. M. Shannon 1 and K. E. Dunleavy 2. 1Southern Research Institute, Birmingham, AL 35255. 2W.R. Grace & Co.-Conn., Lexington, MA 02173
Źródło:
In Antiviral Research 1995 26(3):A274-A274
Czasopismo naukowe
Szczegóły
Tytuł:
Validation of Multiplex Serology for human hepatitis viruses B and C, human T-lymphotropic virus 1 and Toxoplasma gondii.
Autorzy:
Brenner N; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
Mentzer AJ; The Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, United Kingdom.
Butt J; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Braband KL; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Michel A; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Jeffery K; Department of Microbiology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Klenerman P; Department of Microbiology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; NIHR Biomedical Research Centre, Oxford, United Kingdom.
Gärtner B; Institut für Medizinische Mikrobiologie und Hygiene, Universität des Saarlands, Homburg, Germany.
Schnitzler P; Center for Infectious Diseases, Virology, University Hospital of Heidelberg, Heidelberg, Germany.
Hill A; The Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.; The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Taylor G; Molecular Diagnostic Unit, Imperial College Healthcare NHS Trust, London, United Kingdom.
Demontis MA; Molecular Diagnostic Unit, Imperial College Healthcare NHS Trust, London, United Kingdom.
Guy E; Toxoplasma Reference Unit, Public Health Wales Microbiology, Swansea, United Kingdom.
Hadfield SJ; Toxoplasma Reference Unit, Public Health Wales Microbiology, Swansea, United Kingdom.
Almond R; UK Biobank, Stockport, United Kingdom.
Allen N; UK Biobank, Stockport, United Kingdom.; Nuffield Department of Population Health, Medical Sciences Division, University of Oxford, Oxford, United Kingdom.
Pawlita M; Molecular Diagnostics of Oncogenic Infections Division, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Waterboer T; Infections and Cancer Epidemiology, Infection, Inflammation and Cancer Research Program, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Jan 07; Vol. 14 (1), pp. e0210407. Date of Electronic Publication: 2019 Jan 07 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:
Antibodies, Viral/*blood
Antigens/*immunology
HTLV-I Infections/*blood
Hepatitis B/*blood
Hepatitis C/*blood
Serologic Tests/*methods
Toxoplasmosis/*blood
Antibodies, Viral/immunology ; Antigens, Protozoan/immunology ; Antigens, Viral/immunology ; HTLV-I Infections/immunology ; HTLV-I Infections/virology ; Hepacivirus/immunology ; Hepatitis B/immunology ; Hepatitis B/virology ; Hepatitis B virus/immunology ; Hepatitis C/immunology ; Hepatitis C/virology ; High-Throughput Screening Assays ; Human T-lymphotropic virus 1/immunology ; Humans ; Seroepidemiologic Studies ; Toxoplasma/immunology ; Toxoplasmosis/immunology ; Toxoplasmosis/parasitology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Earliest known Oldowan artifacts at >2.58 Ma from Ledi-Geraru, Ethiopia, highlight early technological diversity
Autorzy:
Braun, David R.
Aldeias, Vera
Archer, Will
Arrowsmith, J Ramon
Baraki, Niguss
Campisano, Christopher J.
Deino, Alan L.
DiMaggio, Erin N.
Dupont-Nivet, Guillaume
Engda, Blade
Feary, David A.
Garello, Dominique I.
Kerfelew, Zenash
McPherron, Shannon P.
Patterson, David B.
Reeves, Jonathan S.
Thompson, Jessica C.
Reed, Kaye E.
Pokaż więcej
Źródło:
Proceedings of the National Academy of Sciences of the United States of America, 2019 Jun 01. 116(24), 11712-11717.
Dostęp URL:
https://www.jstor.org/stable/26743474  Link otwiera się w nowym oknie
Czasopismo naukowe
Szczegóły
Tytuł:
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Autorzy:
Pereyra F
Jia X
McLaren PJ
Telenti A
de Bakker PI
Walker BD
Ripke S
Brumme CJ
Pulit SL
Carrington M
Kadie CM
Carlson JM
Heckerman D
Graham RR
Plenge RM
Deeks SG
Gianniny L
Crawford G
Sullivan J
Gonzalez E
Davies L
Camargo A
Moore JM
Beattie N
Gupta S
Crenshaw A
Burtt NP
Guiducci C
Gupta N
Gao X
Qi Y
Yuki Y
Piechocka-Trocha A
Cutrell E
Rosenberg R
Moss KL
Lemay P
O'Leary J
Schaefer T
Verma P
Toth I
Block B
Baker B
Rothchild A
Lian J
Proudfoot J
Alvino DM
Vine S
Addo MM
Allen TM
Altfeld M
Henn MR
Le Gall S
Streeck H
Haas DW
Kuritzkes DR
Robbins GK
Shafer RW
Gulick RM
Shikuma CM
Haubrich R
Riddler S
Sax PE
Daar ES
Ribaudo HJ
Agan B
Agarwal S
Ahern RL
Allen BL
Altidor S
Altschuler EL
Ambardar S
Anastos K
Anderson B
Anderson V
Andrady U
Antoniskis D
Bangsberg D
Barbaro D
Barrie W
Bartczak J
Barton S
Basden P
Basgoz N
Bazner S
Bellos NC
Benson AM
Berger J
Bernard NF
Bernard AM
Birch C
Bodner SJ
Bolan RK
Boudreaux ET
Bradley M
Braun JF
Brndjar JE
Brown SJ
Brown K
Brown ST
Burack J
Bush LM
Cafaro V
Campbell O
Campbell J
Carlson RH
Carmichael JK
Casey KK
Cavacuiti C
Celestin G
Chambers ST
Chez N
Chirch LM
Cimoch PJ
Cohen D
Cohn LE
Conway B
Cooper DA
Cornelson B
Cox DT
Cristofano MV
Cuchural G Jr
Czartoski JL
Dahman JM
Daly JS
Davis BT
Davis K
Davod SM
DeJesus E
Dietz CA
Dunham E
Dunn ME
Ellerin TB
Eron JJ
Fangman JJ
Farel CE
Ferlazzo H
Fidler S
Fleenor-Ford A
Frankel R
Freedberg KA
French NK
Fuchs JD
Fuller JD
Gaberman J
Gallant JE
Gandhi RT
Garcia E
Garmon D
Gathe JC Jr
Gaultier CR
Gebre W
Gilman FD
Gilson I
Goepfert PA
Gottlieb MS
Goulston C
Groger RK
Gurley TD
Haber S
Hardwicke R
Hardy WD
Harrigan PR
Hawkins TN
Heath S
Hecht FM
Henry WK
Hladek M
Hoffman RP
Horton JM
Hsu RK
Huhn GD
Hunt P
Hupert MJ
Illeman ML
Jaeger H
Jellinger RM
John M
Johnson JA
Johnson KL
Johnson H
Johnson K
Joly J
Jordan WC
Kauffman CA
Khanlou H
Killian RK
Kim AY
Kim DD
Kinder CA
Kirchner JT
Kogelman L
Kojic EM
Korthuis PT
Kurisu W
Kwon DS
LaMar M
Lampiris H
Lanzafame M
Lederman MM
Lee DM
Lee JM
Lee MJ
Lee ET
Lemoine J
Levy JA
Llibre JM
Liguori MA
Little SJ
Liu AY
Lopez AJ
Loutfy MR
Loy D
Mohammed DY
Man A
Mansour MK
Marconi VC
Markowitz M
Marques R
Martin JN
Martin HL Jr
Mayer KH
McElrath MJ
McGhee TA
McGovern BH
McGowan K
McIntyre D
Mcleod GX
Menezes P
Mesa G
Metroka CE
Meyer-Olson D
Miller AO
Montgomery K
Mounzer KC
Nagami EH
Nagin I
Nahass RG
Nelson MO
Nielsen C
Norene DL
O'Connor DH
Ojikutu BO
Okulicz J
Oladehin OO
Oldfield EC 3rd
Olender SA
Ostrowski M
Owen WF Jr
Pae E
Parsonnet J
Pavlatos AM
Perlmutter AM
Pierce MN
Pincus JM
Pisani L
Price LJ
Proia L
Prokesch RC
Pujet HC
Ramgopal M
Rathod A
Rausch M
Ravishankar J
Rhame FS
Richards CS
Richman DD
Rodes B
Rodriguez M
Rose RC 3rd
Rosenberg ES
Rosenthal D
Ross PE
Rubin DS
Rumbaugh E
Saenz L
Salvaggio MR
Sanchez WC
Sanjana VM
Santiago S
Schmidt W
Schuitemaker H
Sestak PM
Shalit P
Shay W
Shirvani VN
Silebi VI
Sizemore JM Jr
Skolnik PR
Sokol-Anderson M
Sosman JM
Stabile P
Stapleton JT
Starrett S
Stein F
Stellbrink HJ
Sterman FL
Stone VE
Stone DR
Tambussi G
Taplitz RA
Tedaldi EM
Telenti A
Theisen W
Torres R
Tosiello L
Tremblay C
Tribble MA
Trinh PD
Tsao A
Ueda P
Vaccaro A
Valadas E
Vanig TJ
Vecino I
Vega VM
Veikley W
Wade BH
Walworth C
Wanidworanun C
Ward DJ
Warner DA
Weber RD
Webster D
Weis S
Wheeler DA
White DJ
Wilkins E
Winston A
Wlodaver CG
van't Wout A
Wright DP
Yang OO
Yurdin DL
Zabukovic BW
Zachary KC
Zeeman B
Zhao M
Pokaż więcej
Corporate Authors:
International HIV Controllers Study; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology (MIT) and Harvard, Boston, MA, USA.
Źródło:
Science (New York, N.Y.) [Science] 2010 Dec 10; Vol. 330 (6010), pp. 1551-7. Date of Electronic Publication: 2010 Nov 04.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antigen Presentation*
Genes, MHC Class I*
HIV-1*/immunology
HIV Infections/*genetics
HIV Infections/*immunology
HLA-B Antigens/*genetics
Black or African American/genetics ; Alleles ; Amino Acids/physiology ; CD8-Positive T-Lymphocytes/immunology ; Cohort Studies ; Disease Progression ; Genome-Wide Association Study ; HIV Antigens/immunology ; HIV Infections/ethnology ; HIV Infections/virology ; HIV Long-Term Survivors ; HLA-A Antigens/chemistry ; HLA-A Antigens/genetics ; HLA-A Antigens/immunology ; HLA-A Antigens/metabolism ; HLA-B Antigens/chemistry ; HLA-B Antigens/immunology ; HLA-B Antigens/metabolism ; HLA-C Antigens/chemistry ; HLA-C Antigens/genetics ; HLA-C Antigens/immunology ; HLA-C Antigens/metabolism ; Haplotypes ; Hispanic or Latino/genetics ; Humans ; Immunity, Innate ; Logistic Models ; Models, Molecular ; Polymorphism, Single Nucleotide ; Protein Conformation ; Viral Load ; White People/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Assessment of the state-of-the-art trueness and precision of serum total-calcium and glucose measurements in Finnish laboratories - the QSL-Finland study.
Autorzy:
Linko, S
Himberg, J J
Thienpont, L
Stöckl, D
De Leenheer, A
Pokaż więcej
Temat:
PATHOLOGICAL laboratories
SERUM
GLUCOSE
MEDICAL laboratories
Źródło:
Scandinavian Journal of Clinical & Laboratory Investigation. 7/22/98, Vol. 58 Issue 3, p229-240. 12p.
Terminy geograficzne:
FINLAND
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Vitamin C with metabolites reduce oxalate levels compared to ascorbic acid: a preliminary and novel clinical urologic finding.
Autorzy:
Moyad MA (AUTHOR)
Combs MA (AUTHOR)
Crowley DC (AUTHOR)
Baisley JE (AUTHOR)
Sharma P (AUTHOR)
Vrablic AS (AUTHOR)
Evans M (AUTHOR)
Pokaż więcej
Źródło:
Urologic Nursing. Mar/Apr2009, Vol. 29 Issue 2, p95-102. 8p.
URL:
38714461  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Autorzy:
Matuozzo D; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Talouarn E; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Marchal A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Zhang P; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Manry J; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Seeleuthner Y; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Zhang Y; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, Bethesda, MD, USA.
Bolze A; Helix, San Mateo, CA, USA.
Chaldebas M; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Milisavljevic B; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Gervais A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Bastard P; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Pediatric Hematology-Immunology and Rheumatology Unit, Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Asano T; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Bizien L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.
Barzaghi F; Department of Paediatric Immunohematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Abolhassani H; Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden.; Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran, Iran.
Abou Tayoun A; Genomics Center of Excellence, Al Jalila Children's Specialty Hospital, Dubai, United Arab Emirates.; Center for Genomic Discovery, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates.
Aiuti A; San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCSS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Alavi Darazam I; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Allende LM; Immunology Department, University Hospital 12 de Octubre, Research Institute imas12 and Complutense University, Madrid, Spain.
Alonso-Arias R; Immunology Department, Hospital Universitario Central de Asturias; Health Research Institute of Principality of Asturias, Oviedo, Spain.
Arias AA; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.; Department of Microbiology and Parasitology, Primary Immunodeficiencies Group, School of Medicine, University of Antioquia UdeA, 050010, Medellin, Colombia.; School of Microbiology, University of Antioquia UdeA, 050010, Medellin, Colombia.
Aytekin G; Deparment of Internal Medicine, Division of Allergy and Immunology, Konya City Hospital, Konya, Turkey.
Bergman P; Department of Infectious Diseases, The Immunodeficiency Unit, Karolinska University Hospital, Stockholm, Sweden.; Department of Laboratory Medicine, Division of Clinical Immunology, Stockholm, Sweden.
Bondesan S; Clinical Genomics, IRCSS San Raffaele Scientific Institute, Milan, Italy.
Bryceson YT; Department of Medicine, Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.
Bustos IG; Universidad de La Sabana, Chía, Colombia.
Cabrera-Marante O; Institute of Biomedical Research of IdiPAZ, University Hospital 'La Paz', Madrid, Spain.
Carcel S; Unidad de Gestión Clínica de Cuidados Intensivos, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba (UCO), Córdoba, Spain.
Carrera P; Clinical Genomics, IRCSS San Raffaele Scientific Institute, Milan, Italy.
Casari G; Division of Genetics and Cell Biology, Genome-Phenome Relationship, San Raffaele Hospital, Milan, Italy.; School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Chaïbi K; Intensive Care Unit Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Bobigny, France.; Common and Rare Kidney Diseases, Sorbonne University, INSERM UMR-S 1155, Paris, France.
Colobran R; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Catalonia, Spain.; Translational Immunology Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.; Genetics Department, Immunology Division, Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona (UAB), Barcelona, Catalonia, Spain.
Condino-Neto A; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Covill LE; Department of Medicine, Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden.
Delmonte OM; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, Bethesda, MD, USA.
El Zein L; Biology Department, Lebanese University, Beirut, Lebanon.
Flores C; Genomics Division, Institute of Technology and Renewable Energies (ITER), Santa Cruz de Tenerife, Spain.; CIBER de Enfermedades Respiratorias, Carlos III Health Institute, Madrid, Spain.; Research Unit, University Hospital of Ntra. Sra. de Candelaria, Santa Cruz de Tenerife, Spain.; Faculty of Health Sciences, University of Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.
Gregersen PK; Feinstein Institute for Medical Research, Northwell Health USA, Manhasset, NY, USA.
Gut M; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.
Haerynck F; Department of Internal Diseases and Pediatrics, Primary Immune Deficiency Research Laboratory, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent, Belgium.
Halwani R; Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.
Hancerli S; Department of Pediatrics (Infectious Diseases), Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Hammarström L; Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden.
Hatipoğlu N; Pediatric Infectious Diseases Unit, Bakirkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Karbuz A; Department of Pediatric Infectious Disease, Dr. Cemil Tascioglu City Hospital, Istanbul, Turkey.
Keles S; Meram Medical Faculty, Pediatric Infectious Diseases Department, Necmettin Erbakan University, Konya, Turkey.
Kyheng C; Department of General Paediatrics, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, University of Paris Saclay, Le Kremlin-Bicêtre, France.
Leon-Lopez R; Unidad de Gestión Clínica de Cuidados Intensivos, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba (UCO), Córdoba, Spain.
Franco JL; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia UDEA, Medellin, 050010, Colombia.
Mansouri D; The Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Clinical Immunology and Infectious Diseases, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Pediatric Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Martinez-Picado J; IrsiCaixa AIDS Research Institute and Institute for Health Science Research Germans Trias I Pujol (IGTP), Badalona, Spain.; Institute for Health Science Research Germans Trias I Pujol (IGTP), Badalona, Spain.; Department of Infectious Diseases and Immunity, University of Vic-Central University of Catalonia, Vic, Spain.; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain.; Consorcio Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Metin Akcan O; Meram Medical Faculty, Pediatric Infectious Diseases Department, Necmettin Erbakan University, Konya, Turkey.
Migeotte I; Centre de Génétique Humaine de L'Université Libre de Bruxelles, Hôpital Erasme, Brussels, Belgium.
Morange PE; Laboratory of Haematology, La Timone Hospital, Marseille, France.; C2VN, INSERM, INRAE, Aix-Marseille University, Marseille, France.
Morelle G; Department of General Paediatrics, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, University of Paris Saclay, Le Kremlin-Bicêtre, France.
Martin-Nalda A; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Catalonia, Spain.; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona (UAB), Barcelona, Catalonia, Spain.; Infection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.
Novelli G; Department of Biomedicine and Prevention, Tor Vergata University of Rome, Rome, Italy.; IRCCS Neuromed, Pozzilli, Italy.
Novelli A; Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
Ozcelik T; Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Palabiyik F; Pediatric Infectious Diseases Unit, Bakirkoy Dr Sadi Konuk Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.
Pan-Hammarström Q; Department of Biosciences and Nutrition, Karolinska Institute, Stockholm, Sweden.
de Diego RP; Laboratory of Immunogenetics of Human Diseases, IdiPAZ Institute for Health Research, University Hospital 'La Paz', Madrid, Spain.
Planas-Serra L; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Center for Biomedical Research On Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Pleguezuelo DE; Immunology Department, University Hospital 12 de Octubre, Research Institute imas12 and Complutense University, Madrid, Spain.
Prando C; Faculdades Pequeno Príncipe, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, Brazil.
Pujol A; Catalan Institution of Research and Advanced Studies (ICREA), Barcelona, Spain.; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Center for Biomedical Research On Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Reyes LF; Universidad de La Sabana, Chía, Colombia.
Rivière JG; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Catalonia, Spain.; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona (UAB), Barcelona, Catalonia, Spain.; Infection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.
Rodriguez-Gallego C; Department of Immunology, University Hospital of Gran Canaria Dr. Negrin, Canarian Health System, Las Palmas de Gran Canaria, Spain.; Department of Clinical Sciences, University of Fernando Pessoa Canarias, Las Palmas de Gran Canaria, Spain.
Rojas J; Primary Immunodeficiencies Group, Department of Microbiology and Parasitology, School of Medicine, University of Antioquia UDEA, Medellin, 050010, Colombia.
Rovere-Querini P; Vita-Salute San Raffaele University, Milan, Italy.; Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Schlüter A; Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Catalonia, Spain.; Center for Biomedical Research On Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Shahrooei M; Specialized Immunology Laboratory of Dr Shahrooei, Sina Medical Complex, Ahvaz, Iran.; Department of Microbiology and Immunology, Clinical and Diagnostic Immunology, KU Leuven, Leuven, Belgium.
Sobh A; Department of Pediatrics, Mansoura University Children's Hospital, Mansoura University Faculty of Medicine, Mansoura, Egypt.
Soler-Palacin P; Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, Barcelona, Catalonia, Spain.; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Autonomous University of Barcelona (UAB), Barcelona, Catalonia, Spain.; Infection and Immunity in Pediatric Patients Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital (HUVH), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Catalonia, Spain.
Tandjaoui-Lambiotte Y; Hypoxia and Lung, INSERM U1272, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris, Bobigny, France.
Tipu I; Department of Life Sciences, School of Science, University of Management and Technology, Lahore, Pakistan.
Tresoldi C; Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Troya J; Department of Internal Medicine, Infanta Leonor University Hospital, Madrid, Spain.
van de Beek D; Department of Neurology, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, Netherlands.
Zatz M; Biosciences Institute, University of São Paulo, São Paulo, Brazil.
Zawadzki P; Gordion Bioscience Inc, Cambridge, MA, USA.; Faculty of Physics, Adam Mickiewicz University, Poznan, Poland.
Al-Muhsen SZ; Department of Pediatrics, Immunology Research Laboratory, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Alosaimi MF; Department of Pediatrics, Immunology Research Laboratory, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Alsohime FM; Department of Pediatrics, Immunology Research Laboratory, College of Medicine and King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Baris-Feldman H; The Genetics Institute, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Butte MJ; Departments of Pediatrics and Microbiology, Immunology, and Molecular Genetics, Division of Immunology, Allergy, and Rheumatology, University of California Los Angeles, Los Angeles, CA, USA.
Constantinescu SN; Ludwig Institute for Cancer Research, Brussels, Belgium.; SIGN Unit, de Duve Institute, Université Catholique de Louvain, Brussels, Belgium.; WELBIO (Walloon Excellence in Life Sciences and Biotechnology), Brussels, Belgium.; Nuffield Department of Medicine, Ludwig Institute for Cancer Research, Oxford University, Oxford, UK.
Cooper MA; Department of Pediatrics, Division of Rheumatology/Immunology, Washington University in St. Louis, St. Louis, MO, USA.
Dalgard CL; The American Genome Center, Uniformed Services University of the Health Sciences, Bethesda, USA.; Department of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Fellay J; School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.; Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Heath JR; Institute for Systems Biology, Seattle, WA, USA.
Lau YL; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.
Lifton RP; Laboratory of Genetics and Genomics, The Rockefeller University, New York, NY, USA.; Department of Genetics, Yale University School of Medicine, New Haven, CT, USA.; Yale Center for Genome Analysis, Yale School of Medicine, New Haven, CT, USA.
Maniatis T; Zukerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA.; New York Genome Center, New York, NY, USA.
Mogensen TH; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
von Bernuth H; Department of Paediatric Respiratory Medicine, Immunology, and Critical Care Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Lermine A; Laboratoire de Biologie Médicale Multisites Seqoia, MG2025, MG2025, Paris, France.
Vidaud M; Laboratoire de Biologie Médicale Multisites Seqoia, MG2025, MG2025, Paris, France.
Boland A; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.
Deleuze JF; Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine (CNRGH), Evry, France.
Nussbaum R; Invitae, San Francisco, CA, USA.
Kahn-Kirby A; Invitae, San Francisco, CA, USA.
Mentre F; Unité de Recherche Clinique, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France.
Tubiana S; Centre d'Investigation Clinique, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France.
Gorochov G; Sorbonne Université, INSERM Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Département d'immunologie Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Tubach F; Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié Salpêtrière, Département de Santé Publique, Unité de Recherche Clinique PSL-CFX , CIC-1901, Paris, France.
Hausfater P; Emergency Department, Hôpital Pitié-Salpêtrière, APHP-Sorbonne Université, Paris, France.; GRC-14 BIOFAST Sorbonn Université, UMR INSERM 1135, CIMI, Sorbonne Université, Paris, France.
Meyts I; Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium.
Zhang SY; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Puel A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Notarangelo LD; Laboratory of Host Defenses, NIAID, National Institutes of Health, Bethesda, MA, USA.
Boisson-Dupuis S; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Su HC; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, NIAID, Bethesda, MD, USA.
Boisson B; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Jouanguy E; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Casanova JL; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France. .; University Paris Cité, Imagine Institute, Paris, France. .; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. .; Howard Hughes Medical Institute, New York, NY, USA. .
Zhang Q; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Abel L; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France.; University Paris Cité, Imagine Institute, Paris, France.; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
Cobat A; Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, Paris, France. .; University Paris Cité, Imagine Institute, Paris, France. .; St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA. .
Pokaż więcej
Corporate Authors:
COVID Human Genetic Effort
COVIDeF Study Group
French COVID Cohort Study Group
CoV-Contact Cohort
COVID-STORM Clinicians
COVID Clinicians
Orchestra Working Group
Amsterdam UMC Covid-19 Biobank
NIAID-USUHS COVID Study Group
Źródło:
Genome medicine [Genome Med] 2023 Apr 05; Vol. 15 (1), pp. 22. Date of Electronic Publication: 2023 Apr 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
MeSH Terms:
COVID-19*
Interferon Type I*
Humans ; Young Adult ; Adult ; Middle Aged ; SARS-CoV-2 ; Toll-Like Receptor 3/genetics ; Toll-Like Receptor 7 ; Autoantibodies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1892967

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz